Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
CALL
NovaGold Resources
NG
$2.66B
| $354K | ﹤0.01% |
72,600
-44,300
| -38% | -$234K |
|
5227
CALL
Caesarstone
CSTE
$71.6M
| $352K | ﹤0.01% |
9,700
+700
| +8% | +$22.5K |
|
5228
CALL
Service Corp International
SCI
$11.8B
| $352K | ﹤0.01% |
11,400
| – | – |
|
5229
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$581M
| $351K | ﹤0.01% |
10,493
-608
| -5% | -$19.9K |
|
|
NNA
5230
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $351K | ﹤0.01% |
13,610
-1,120
| -8% | -$30.8K |
|
|
CAVM
5231
PUT
DELISTED
Cavium, Inc.
CAVM
| $351K | ﹤0.01% |
4,900
-29,000
| -86% | -$1.94M |
|
|
NDRM
5232
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $351K | ﹤0.01% |
13,236
-7,493
| -36% | -$186K |
|
5233
Lennar Class B
LEN.B
$19.7B
| $350K | ﹤0.01% |
8,993
-11,237
| -56% | -$401K |
|
5234
Lesaka Technologies
LSAK
$399M
| $350K | ﹤0.01% |
28,587
-14,228
| -33% | -$179K |
|
|
DNKN
5235
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $350K | ﹤0.01% |
6,400
-139,600
| -96% | -$7.49M |
|
5236
CALL
MGIC Investment
MTG
$6.44B
| $349K | ﹤0.01% |
34,500
-167,100
| -83% | -$1.76M |
|
|
FLY
5237
DELISTED
Fly Leasing Limited
FLY
| $349K | ﹤0.01% |
+26,575
| New | +$364K |
|
|
CLSD
5238
DELISTED
Clearside Biomedical
CLSD
| $348K | ﹤0.01% |
2,923
+731
| +33% | +$86.3K |
|
5239
PUT
Jacobs Solutions
J
$15.7B
| $348K | ﹤0.01% |
7,617
-10,155
| -57% | -$480K |
|
5240
Navios Maritime Partners
NMM
$2.25B
| $348K | ﹤0.01% |
11,211
-35
| -0.3% | -$970 |
|
5241
Ooma
OOMA
$589M
| $348K | ﹤0.01% |
34,966
+12,923
| +59% | +$124K |
|
5242
Univest Financial
UVSP
$1.22B
| $348K | ﹤0.01% |
13,428
+1,761
| +15% | +$49.4K |
|
|
TPCO
5243
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $348K | ﹤0.01% |
24,993
-25,707
| -51% | -$353K |
|
|
CERN
5244
PUT
DELISTED
Cerner Corp
CERN
| $347K | ﹤0.01% |
5,900
-29,300
| -83% | -$1.58M |
|
|
PETX
5245
DELISTED
Aratana Therapeutics, Inc.
PETX
| $347K | ﹤0.01% |
65,415
+5,165
| +9% | +$34.9K |
|
|
PF
5246
CALL
DELISTED
Pinnacle Foods, Inc.
PF
| $347K | ﹤0.01% |
6,000
-26,100
| -81% | -$1.45M |
|
|
ACTA
5247
DELISTED
Actua Corp
ACTA
| $347K | ﹤0.01% |
24,708
-1,941
| -7% | -$27.2K |
|
5248
PUT
ProShares Ultra Silver
AGQ
$1.2B
| $346K | ﹤0.01% |
8,400
-16,500
| -66% | -$632K |
|
5249
CALL
AMC Entertainment Holdings
AMC
$2.47B
| $346K | ﹤0.01% |
1,100
+1,090
| +10,900% | +$348K |
|
|
GTLS
5250
CALL
DELISTED
Chart Industries
GTLS
| $346K | ﹤0.01% |
9,900
-1,200
| -11% | -$44.4K |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.